Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 674

1.

Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.

Leiter LA, Lewanczuk RZ.

Am J Hypertens. 2005 Jan;18(1):121-8. Review.

PMID:
15691626
2.
3.

Involvement of the pancreatic renin-angiotensin system in insulin resistance and the metabolic syndrome.

Leung PS, de Gasparo M.

J Cardiometab Syndr. 2006 Summer;1(3):197-203. Review.

4.

Improvement of insulin sensitivity by antagonism of the renin-angiotensin system.

Henriksen EJ.

Am J Physiol Regul Integr Comp Physiol. 2007 Sep;293(3):R974-80. Epub 2007 Jun 20. Review.

5.

Role of renin-angiotensin system blockade in patients with diabetes mellitus.

Braga MF, Leiter LA.

Am J Cardiol. 2009 Sep 15;104(6):835-9. doi: 10.1016/j.amjcard.2009.05.015. Review.

PMID:
19733720
7.

Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes.

Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME.

J Hypertens. 2005 Mar;23(3):463-73. Review.

PMID:
15716683
9.

Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus.

Hayashi T, Takai S, Yamashita C.

Curr Vasc Pharmacol. 2010 Mar;8(2):189-97. Review.

PMID:
19485896
10.

The renin angiotensin system as a therapeutic target to prevent diabetes and its complications.

Vijayaraghavan K, Deedwania PC.

Cardiol Clin. 2005 May;23(2):165-83. Review.

PMID:
15694745
11.

Free fatty acids and type 2 diabetes mellitus.

Wyne KL.

Am J Med. 2003 Dec 8;115 Suppl 8A:29S-36S. Review.

PMID:
14678863
12.

The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.

Perkins JM, Davis SN.

Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):147-52. doi: 10.1097/MED.0b013e3282f7026f. Review.

PMID:
18316950
13.

Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.

Cooper SA, Whaley-Connell A, Habibi J, Wei Y, Lastra G, Manrique C, Stas S, Sowers JR.

Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2009-23. Epub 2007 Jun 22. Review.

14.
15.

The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention.

Muscogiuri G, Chavez AO, Gastaldelli A, Perego L, Tripathy D, Saad MJ, Velloso L, Folli F.

Curr Vasc Pharmacol. 2008 Oct;6(4):301-12. Review.

PMID:
18855718
16.
17.

[Progress in the prevention of type 2 diabetes].

Schernthaner G.

Wien Klin Wochenschr. 2003 Nov 28;115(21-22):745-57. Review. German.

PMID:
14743578
18.

Inflammation and the metabolic syndrome: role of angiotensin II and oxidative stress.

Ferder L, Inserra F, Martínez-Maldonado M.

Curr Hypertens Rep. 2006 Jun;8(3):191-8. Review.

PMID:
17147916
19.

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

Evans JL, Goldfine ID, Maddux BA, Grodsky GM.

Diabetes. 2003 Jan;52(1):1-8. Review.

20.

Protection of pancreatic beta-cells: is it feasible?

Bonora E.

Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):74-83. Review.

PMID:
18096375
Items per page

Supplemental Content

Write to the Help Desk